- Published at
- by gurufocus.com
neutral
neutral
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial Adjustments
Revenue: CHF0.1 million in Q3 2024, compared to CHF0.3 million in Q3 2023.R&D Expenses: CHF0.2 million in Q3 2024, decreased by CHF0.3 million from Q3 2023.G&A